Erlotinib resistance in Lung Cancer: Current Progress and Future Perspectives

• Κύριοι συγγραφείς: Joy eTang (Συγγραφέας), Rasha eSalama (Συγγραφέας), Shirish M Gadgeel (Συγγραφέας), Fazlul H Sarkar (Συγγραφέας), Aamir eAhmad (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2013-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Lung cancer is the most common cancer in the world. Despite modern advancements in surgeries, chemotherapies and radiotherapies over the past few years, lung cancer still remains a very difficult disease to treat. This has left the death rate from lung cancer victims largely unchanged throughout the...